PRESS RELEASE published on 10/21/2025 at 10:42, 8 months 2 days ago Franchissement de seuils Déclaration de franchissement de seuils par Vester Finance pour ADOCIA avec 889 555 actions, 4,86% du capital et 4,36% des droits de vote Déclaration Actions Franchissement De Seuils ADOCIA Vester Finance
BRIEF published on 10/15/2025 at 08:50, 8 months 8 days ago Résultats positifs pour l'insuline BioChaperone® Lispro en Phase 3 Essai Clinique Diabète De Type 1 ADOCIA BioChaperone® Tonghua Dongbao
BRIEF published on 10/15/2025 at 08:50, 8 months 8 days ago Positive results for BioChaperone® Lispro insulin in Phase 3 Clinical Trial Type 1 Diabetes ADOCIA BioChaperone® Tonghua Dongbao
PRESS RELEASE published on 10/15/2025 at 08:45, 8 months 8 days ago Inside Information / Other news releases ADOCIA and Tonghua Dongbao announce positive Phase 3 results for Ultra-Rapid Insulin BioChaperone Lispro in Type 1 Diabetes treatment, showing non-inferior HbA1c reduction and improved blood glucose control post-meal Type 1 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
PRESS RELEASE published on 10/15/2025 at 08:45, 8 months 8 days ago Informations privilégiées / Autres communiqués Adocia et Tonghua Dongbao annoncent des résultats positifs d'essai clinique de Phase 3 sur l'insuline BioChaperone® Lispro THDB0206 injection pour le Diabète de Type 1 en Chine Diabète De Type 1 ADOCIA Tonghua Dongbao Insuline BioChaperone Lispro
BRIEF published on 07/25/2025 at 08:50, 10 months 29 days ago Adocia et Tonghua Dongbao annoncent le succès de la phase 3 de leur projet d'insuline ultra-rapide Essai Clinique Traitement Du Diabète ADOCIA Résultats De La Phase 3 BioChaperone® Lispro
BRIEF published on 07/25/2025 at 08:50, 10 months 29 days ago Adocia and Tonghua Dongbao Report Phase 3 Success for Ultra-Rapid Insulin Diabetes Treatment Clinical Trial Phase 3 Results ADOCIA BioChaperone® Lispro
PRESS RELEASE published on 07/25/2025 at 08:45, 10 months 29 days ago Informations privilégiées / Autres communiqués ADOCIA et Tonghua Dongbao annoncent des résultats positifs de l'essai clinique de Phase 3 sur l'insuline ultra-rapide BioChaperone® Lispro pour le diabète de Type 2 en Chine Essai Clinique Diabète De Type 2 ADOCIA Tonghua Dongbao Insuline Ultra-rapide
PRESS RELEASE published on 07/25/2025 at 08:45, 10 months 29 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 1 year 2 months ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
Published on 06/24/2026 at 00:00, 3 hours 8 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 3 hours 23 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 3 hours 48 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 3 hours 53 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/23/2026 at 23:00, 4 hours 8 minutes ago International Battery Metals Ltd. Announces RSU Grant
Published on 06/24/2026 at 02:05, 1 hour 3 minutes ago FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Published on 06/23/2026 at 22:20, 4 hours 48 minutes ago Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 6 hours 53 minutes ago EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:30, 8 hours 38 minutes ago IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 19:47, 7 hours 20 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 7 hours 20 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 7 hours 58 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 7 hours 58 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 8 hours 36 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
